News

Evaluation of the innovative biomolecular analysis tool from FOx Biosystems initiated at the VIB research institute
15 May 2018
FOx Biosystems, a biosensor company, and VIB announced today that VIB will become an important research institute to evaluate the White FOx 1.0 in its workflows as part of its vision for adopting breakthrough technologies.
VIB scientists Jenny Russinova and Patrik Verstreken elected as EMBO Members
15 May 2018
EMBO elected 62 outstanding life scientists to its membership, joining a group of more than 1800 of the best researchers in Europe and around the world.
Alzheimer’s antibody developed by VIB goes US
12 May 2018
VIB has signed an exclusive license & collaboration agreement with new-kid-on-the-stock-market Denali Therapeutics. The biotech company specializes in treating neurodegenerative diseases through rigorous therapeutic discovery and development
Scientists uncover new genetic cause of lupus
9 May 2018
Scientists and clinicians at VIB, KU Leuven and UZ Leuven identified a novel mutation causing an unusual form of the autoimmune disease lupus. The findings are published in the week leading up to World Lupus Day
Joost Schymkowitz and Frederic Rousseau on the dawn of Aelin Therapeutics
27 April 2018
VIB's 20th spin-off Aelin Therapeutics has just been launched, and Joost and Frederic’s coveted technology platform is now up and running.
2018 Heineken Prize for Medicine for Prof Peter Carmeliet for his pioneering research on blood vessel formation
24 April 2018
Peter Carmeliet from the VIB-KU Leuven Center for Cancer Biology has been awarded the prestigious 2018 Heineken Prize for Medicine for his important and fundamental research into blood vessel formation.
VIB Tech Watch Innovation Lab update 10x genomics’ tech fuels single-cell studies at VIB
20 April 2018
The 10x Genomics’ GemCode Technology makes it possible to study the genetic and transcriptional information of an organism at the single-cell level. Early in its development, this technology was spotted by the VIB Tech Watch initiative.
VIB presents its 2017 annual results and confirms its reputation as global player
19 April 2018
VIB presents its results in its 2017 annual report. Here is a limited selection of implementations from the past year that will have a significant impact on our society.
Quickscan 2018
13 April 2018
VIB's scientific publications 1st quarter 2018
Competitive ERC Advanced Grant awarded to Bart Lambrecht to study the role of protein crystallization in asthma
6 April 2018
Bart Lambrecht (VIB-UGent Center for Inflammation Research) is awarded an Advanced Grant. To qualify, a scientist has to be able to prove exceptional leadership and a solid track record of significant research achievements over at least 10 years.
Major international cancer award for Peter Carmeliet
5 April 2018
Peter Carmeliet (VIB-KU Leuven Center for Cancer Biology) was honored with the 46th annual ARC Foundation Leopold Griffuel Award, a prize of EUR 150,000.
Molecular details of protein crystal nucleation uncovered
4 April 2018
A team of researchers led by Dr. Mike Sleutel from the VIB-VUB Center for Structural Biology in collaboration with scientists from Eindhoven and Grenoble, have for the first time uncovered the molecular details of protein crystal nucleation.
After hours: How practice makes perfect for violinist Laure-Anne Teuwen
22 March 2018
When she’s not playing her violin or climbing mountains, Laure-Anne is conducting cancer research at the Peter Carmeliet Lab (VIB-KU Leuven Center for Cancer Biology) as a 3rd-year PhD student.
European scientists unite to track all cells in the human body
22 March 2018
A consortium of European researchers will develop & apply new technologies to profile virtually all individual cells within the human body & track how they change during ageing & disease. Stein Aerts and Chris Marine (VIB-KU Leuven) are Belgian partners
Omics@VIB: fertile soil for tight postdoc communities
21 March 2018
The Omics@VIB program – cofounded by EU FP7 MSCA – orients young scientists from diverse backgrounds toward one goal: becoming experts in omics techniques for life sciences.

«Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS